Novel quinazolin-sulfonamid derivatives: synthesis, characterization, biological evaluation, and molecular docking studies. 2022

Nima Sepehri, and Maryam Mohammadi-Khanaposhtani, and Nafise Asemanipoor, and Samanesadat Hosseini, and Mahmood Biglar, and Bagher Larijani, and Mohammad Mahdavi, and Haleh Hamedifar, and Parham Taslimi, and Nastaran Sadeghian, and Mostafa Norizadehtazehkand, and Ilhami Gulcin
Nano Alvand Company, Avicenna Tech Park, Tehran University of Medical Sciences, Tehran, Iran.

In the design of novel drugs, the formation of hybrid molecules via the combination of several pharmacophores can give rise to compounds with interesting biochemical profiles. A series of novel quinazolin-sulfonamid derivatives (9a-m) were synthesized, characterized and evaluated for their in vitro antidiabetic, anticholinergics, and antiepileptic activity. These synthesized novel quinazolin-sulfonamid derivatives (9a-m) were found to be effective inhibitor molecules for the α-glycosidase, human carbonic anhydrase I and II (hCA I and hCA II), butyrylcholinesterase (BChE) and acetylcholinesterase (AChE) enzyme, with Ki values in the range of 100.62 ± 13.68-327.94 ± 58.21 nM for α-glycosidase, 1.03 ± 0.11-14.87 ± 2.63 nM for hCA I, 1.83 ± 0.24-15.86 ± 2.57 nM for hCA II, 30.12 ± 3.81-102.16 ± 13.87 nM for BChE, and 26.16 ± 3.63-88.52 ± 20.11 nM for AChE, respectively. In the last step, molecular docking calculations were made to compare biological activities of molecules against enzymes which are achethylcholinesterase, butyrylcholinesterase and α-glycosidase.Communicated by Ramaswamy H. Sarma.

UI MeSH Term Description Entries
D002091 Butyrylcholinesterase An aspect of cholinesterase (EC 3.1.1.8). Pseudocholinesterase,Benzoylcholinesterase,Butyrylthiocholinesterase
D002800 Cholinesterase Inhibitors Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. Acetylcholinesterase Inhibitor,Acetylcholinesterase Inhibitors,Anti-Cholinesterase,Anticholinesterase,Anticholinesterase Agent,Anticholinesterase Agents,Anticholinesterase Drug,Cholinesterase Inhibitor,Anti-Cholinesterases,Anticholinesterase Drugs,Anticholinesterases,Cholinesterase Inhibitors, Irreversible,Cholinesterase Inhibitors, Reversible,Agent, Anticholinesterase,Agents, Anticholinesterase,Anti Cholinesterase,Anti Cholinesterases,Drug, Anticholinesterase,Drugs, Anticholinesterase,Inhibitor, Acetylcholinesterase,Inhibitor, Cholinesterase,Inhibitors, Acetylcholinesterase,Inhibitors, Cholinesterase,Inhibitors, Irreversible Cholinesterase,Inhibitors, Reversible Cholinesterase,Irreversible Cholinesterase Inhibitors,Reversible Cholinesterase Inhibitors
D006026 Glycoside Hydrolases Any member of the class of enzymes that catalyze the cleavage of the glycosidic linkage of glycosides and the addition of water to the resulting molecules. Endoglycosidase,Exoglycosidase,Glycohydrolase,Glycosidase,Glycosidases,Glycoside Hydrolase,Endoglycosidases,Exoglycosidases,Glycohydrolases,Hydrolase, Glycoside,Hydrolases, Glycoside
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000110 Acetylcholinesterase An enzyme that catalyzes the hydrolysis of ACETYLCHOLINE to CHOLINE and acetate. In the CNS, this enzyme plays a role in the function of peripheral neuromuscular junctions. EC 3.1.1.7. Acetylcholine Hydrolase,Acetylthiocholinesterase,Hydrolase, Acetylcholine
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

Nima Sepehri, and Maryam Mohammadi-Khanaposhtani, and Nafise Asemanipoor, and Samanesadat Hosseini, and Mahmood Biglar, and Bagher Larijani, and Mohammad Mahdavi, and Haleh Hamedifar, and Parham Taslimi, and Nastaran Sadeghian, and Mostafa Norizadehtazehkand, and Ilhami Gulcin
February 2018, Computational biology and chemistry,
Nima Sepehri, and Maryam Mohammadi-Khanaposhtani, and Nafise Asemanipoor, and Samanesadat Hosseini, and Mahmood Biglar, and Bagher Larijani, and Mohammad Mahdavi, and Haleh Hamedifar, and Parham Taslimi, and Nastaran Sadeghian, and Mostafa Norizadehtazehkand, and Ilhami Gulcin
June 2020, RSC advances,
Nima Sepehri, and Maryam Mohammadi-Khanaposhtani, and Nafise Asemanipoor, and Samanesadat Hosseini, and Mahmood Biglar, and Bagher Larijani, and Mohammad Mahdavi, and Haleh Hamedifar, and Parham Taslimi, and Nastaran Sadeghian, and Mostafa Norizadehtazehkand, and Ilhami Gulcin
January 2016, Iranian journal of pharmaceutical research : IJPR,
Nima Sepehri, and Maryam Mohammadi-Khanaposhtani, and Nafise Asemanipoor, and Samanesadat Hosseini, and Mahmood Biglar, and Bagher Larijani, and Mohammad Mahdavi, and Haleh Hamedifar, and Parham Taslimi, and Nastaran Sadeghian, and Mostafa Norizadehtazehkand, and Ilhami Gulcin
April 2016, Bioorganic & medicinal chemistry letters,
Nima Sepehri, and Maryam Mohammadi-Khanaposhtani, and Nafise Asemanipoor, and Samanesadat Hosseini, and Mahmood Biglar, and Bagher Larijani, and Mohammad Mahdavi, and Haleh Hamedifar, and Parham Taslimi, and Nastaran Sadeghian, and Mostafa Norizadehtazehkand, and Ilhami Gulcin
October 2012, Bioorganic & medicinal chemistry letters,
Nima Sepehri, and Maryam Mohammadi-Khanaposhtani, and Nafise Asemanipoor, and Samanesadat Hosseini, and Mahmood Biglar, and Bagher Larijani, and Mohammad Mahdavi, and Haleh Hamedifar, and Parham Taslimi, and Nastaran Sadeghian, and Mostafa Norizadehtazehkand, and Ilhami Gulcin
June 2019, Archiv der Pharmazie,
Nima Sepehri, and Maryam Mohammadi-Khanaposhtani, and Nafise Asemanipoor, and Samanesadat Hosseini, and Mahmood Biglar, and Bagher Larijani, and Mohammad Mahdavi, and Haleh Hamedifar, and Parham Taslimi, and Nastaran Sadeghian, and Mostafa Norizadehtazehkand, and Ilhami Gulcin
February 2021, Molecular diversity,
Nima Sepehri, and Maryam Mohammadi-Khanaposhtani, and Nafise Asemanipoor, and Samanesadat Hosseini, and Mahmood Biglar, and Bagher Larijani, and Mohammad Mahdavi, and Haleh Hamedifar, and Parham Taslimi, and Nastaran Sadeghian, and Mostafa Norizadehtazehkand, and Ilhami Gulcin
August 2019, Bioorganic chemistry,
Nima Sepehri, and Maryam Mohammadi-Khanaposhtani, and Nafise Asemanipoor, and Samanesadat Hosseini, and Mahmood Biglar, and Bagher Larijani, and Mohammad Mahdavi, and Haleh Hamedifar, and Parham Taslimi, and Nastaran Sadeghian, and Mostafa Norizadehtazehkand, and Ilhami Gulcin
July 2021, Antibiotics (Basel, Switzerland),
Nima Sepehri, and Maryam Mohammadi-Khanaposhtani, and Nafise Asemanipoor, and Samanesadat Hosseini, and Mahmood Biglar, and Bagher Larijani, and Mohammad Mahdavi, and Haleh Hamedifar, and Parham Taslimi, and Nastaran Sadeghian, and Mostafa Norizadehtazehkand, and Ilhami Gulcin
August 2013, European journal of medicinal chemistry,
Copied contents to your clipboard!